AVADEL PHARMACEUTICALS PLC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Avadel Pharmaceuticals Plc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Avadel Pharmaceuticals Plc Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 500M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 500M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 500M 0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 500M 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 500M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 500M 0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 500M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 500M 0 0% Dec 31, 2022 10-K 2024-02-29
Q3 2022 500M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 500M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 500M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 500M 0 0% Dec 31, 2021 10-K 2023-03-29
Q3 2021 500M 0 0% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 500M 0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 500M 0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 500M 0 0% Dec 31, 2020 10-K 2022-03-16
Q3 2020 500M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 500M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 500M 0 0% Dec 31, 2019 10-K 2021-03-09
Q3 2019 500M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 500M 0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 500M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 500M 0 0% Dec 31, 2018 10-K 2020-03-16
Q3 2018 500M 0 0% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 500M 0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 500M 0 0% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 500M 0 0% Dec 31, 2017 10-Q 2019-08-09
Q3 2017 500M +447M +840% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 500M +447M +840% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 500M +500M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 500M +447M +840% Dec 31, 2016 10-K 2019-03-15
Q3 2016 53.2M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 53.2M +629K +1.2% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 53.2K* -52.5M Mar 31, 2016 10-Q 2016-05-10
Q4 2015 53.2M -20K -0.04% Dec 31, 2015 10-K 2017-03-28
Q2 2015 52.5M +6.28M +13.6% Jun 30, 2015 6-K 2015-12-31
Q1 2015 52.5M +5.82M +12.5% Mar 31, 2015 6-K 2015-07-10
Q4 2014 53.2M +18.8M +54.7% Dec 31, 2014 10-K 2016-03-15
Q3 2014 51.9M +17.3M +50% Sep 30, 2014 6-K 2014-11-17
Q2 2014 46.3M +11.5M +33.1% Jun 30, 2014 6-K 2014-08-08
Q1 2014 46.7M Mar 31, 2014 6-K 2014-07-08
Q4 2013 34.4M 0 0% Dec 31, 2013 20-F/A 2015-10-01
Q3 2013 34.6M Sep 30, 2013 6-K 2014-01-15
Q2 2013 34.8M +741K +2.18% Jun 30, 2013 6-K 2013-12-06
Q4 2012 34.4M +448K +1.32% Dec 31, 2012 20-F/A 2014-04-30
Q2 2012 34M Jun 30, 2012 6-K 2012-12-14
Q1 2012 29.7M Mar 31, 2012 6-K 2012-09-13
Q4 2011 33.9M +4.09M +13.7% Dec 31, 2011 20-F 2013-04-30
Q4 2010 29.8M Dec 31, 2010 20-F 2012-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.